Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy. Patent law has a significant influence on drug ...

SHANGHAI, Feb 9 (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals ...

Lydia E. Pinkham’s Vegetable Compound was one of thousands of popular and lucrative patent medicines—health concoctions dreamed up by chemists, housewives, and entrepreneurs—that took the ...

Axsome Therapeutics gained more than $1 billion in market value Monday, after the brain drug developer disclosed a patent ...

President Donald Trump’s health secretary nominee last week indicated he’d consider authorizing the government to seize the patents of high-priced medicines from manufacturers and share them ...

Clearmind Medicine Inc., a Vancouver-based biotech company specializing in psychedelic-derived therapeutics, announced the publication of a new patent by Mexico's National Patent Office.

The patent refers to the Company’s innovative ... including Palmitoylethanolamide (PEA). About Clearmind Medicine Inc. Clearmind is a clinical-stage psychedelic pharmaceutical biotech company ...